EUCTR2011-001218-32-ES进行中（未招募）不适用
Randomized phase II b study of Cabazitaxel in metastatic Colorectal Cancer resistant to standard treatment
Rafael López López0 个研究点开始时间: 2012年4月17日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 55
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 14
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Cabazitaxel compared to topotecan for the treatment of small cell lung cancerSmall Cell Lung CancerEUCTR2011-003415-31-ESSanofi-aventis Recherche & Développement179
进行中（未招募）
不适用
Cabazitaxel compared to topotecan for the treatment of small cell lung cancerSmall Cell Lung CancerEUCTR2011-003415-31-PLSanofi-aventis Recherche & Développement172
进行中（未招募）
不适用
Pharmacokinetics and safety study of cabazitaxel in cancer patients with renal impairmentMedDRA version: 14.1Level: LLTClassification code 10041067Term: Small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Small Cell Lung CancerEUCTR2011-003415-31-ITSANOFI- AVENTIS RECHERCHE ET DÉVELOPPEMENT172
进行中（未招募）
不适用
Cabazitaxel compared to topotecan for the treatment of small cell lungcancerMedDRA version: 16.0Level: LLTClassification code 10041071Term: Small cell lung cancer stage unspecifiedSystem Organ Class: 100000004864Small Cell Lung CancerEUCTR2011-003415-31-DESanofi-aventis Recherche & Développement172
进行中（未招募）
不适用
Cabazitaxel compared to topotecan for the treatment of small cell lung cancerMedDRA version: 14.1Level: PTClassification code 10041071Term: Small cell lung cancer stage unspecifiedSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Small Cell Lung CancerEUCTR2011-003415-31-GRSanofi-aventis Recherche & Développement172